Your browser doesn't support javascript.
loading
Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes.
Fei, Yutong; Guyatt, Gordon Henry; Alexander, Paul Elias; El Dib, Regina; Siemieniuk, Reed A C; Vandvik, Per Olav; Nunnally, Mark E; Gomaa, Huda; Morgan, Rebecca L; Agarwal, Arnav; Zhang, Ying; Bhatnagar, Neera; Spencer, Frederick A.
Afiliação
  • Fei Y; Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Guyatt GH; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Alexander PE; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • El Dib R; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Siemieniuk RAC; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Vandvik PO; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Nunnally ME; Department of Anaesthesiology, Botucatu Medical School, Unesp - Univ Estadual Paulista, São Paulo, Brazil.
  • Gomaa H; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Morgan RL; Department of Medicine, Innlandet Hospital Trust-Division Gjøvik, Oppland, Norway.
  • Agarwal A; New york University School of Medicine, New York, US.
  • Zhang Y; Department of Pharmacy, Tanta Chest Hospital, Tanta, Egypt.
  • Bhatnagar N; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Spencer FA; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
J Eval Clin Pract ; 24(1): 222-231, 2018 02.
Article em En | MEDLINE | ID: mdl-28090731
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Ezetimiba Limite: Humans Idioma: En Ano de publicação: 2018
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases / Ezetimiba Limite: Humans Idioma: En Ano de publicação: 2018